Jim Simons In8 Bio, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in In8 Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 119,155 shares of INAB stock, worth $141,794. This represents 0.0% of its overall portfolio holdings.
Number of Shares
119,155
Previous 19,578
508.62%
Holding current value
$141,794
Previous $27,000
422.22%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INAB
# of Institutions
33Shares Held
8.64MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.87MShares$3.42 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$1.69 Million0.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$1.33 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY615KShares$731,5570.06% of portfolio
-
Sigma Planning Corp Ann Arbor, MI515KShares$612,9450.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $29.2M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...